Healthcare & Medical Devices Global On demand · 24-48h

Global Soft Tissue Puncture Biopsy Needle Market Strategic Research Report

Global Soft Tissue Puncture Biopsy Needle Market Strategic R…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Soft Tissue Puncture Biopsy Needle Market
$1.21B2025
8.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Fully Automatic, Semi-automatic and Manual

By Application: Public Hospital, Private Hospital

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: BD, Mammotome, Medtronic, Merit Medical Systems, Cook, Boston Scientific, Olympus, ConMed, Micro-tech, KDL, Medax, Sterylab, Hologic, Weigao, Puang Medical, Shanghai Aisiai

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 140 pages
Market size 2025
$1.21B
Billion USD
Forecast CAGR
8.3%
2025-2032
Forecast 2032
$2.1B
Projected
Regiões
5
Asia Pacific · Latin America · MEA · Europe · North America

Visão geral

Scope of the Report

The global Soft Tissue Puncture Biopsy Needle market size is predicted to grow from US$ 1,214 million in 2025 to US$ 2,100 million in 2032; it is expected to grow at a CAGR of 8.3% from 2026 to 2032.

A needle biopsy is a procedure to obtain a sample of cells from your body for laboratory testing.

The soft tissue puncture biopsy needle market is driven by the increasing incidence of cancer and the growing demand for minimally invasive diagnostic procedures. Soft tissue biopsy needles are essential tools for obtaining tissue samples from tumors and lesions for accurate diagnosis and treatment planning. The rise in the prevalence of cancer and the need for early and precise diagnosis contribute to market growth. Moreover, advancements in biopsy needle technology, such as improved design, enhanced visualization, and reduced risk of complications, further fuel market expansion. However, the market also faces challenges, including the need for specialized training for healthcare professionals to perform biopsy procedures safely and effectively. Additionally, the availability of alternative diagnostic methods and cost considerations can pose obstacles for widespread adoption. To succeed, companies must focus on continuous innovation, collaborate with healthcare providers to enhance procedural outcomes, and address cost concerns to meet the increasing demand for soft tissue puncture biopsy needles in cancer diagnosis and treatment.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Soft Tissue Puncture Biopsy Needle market?

What factors are driving Soft Tissue Puncture Biopsy Needle market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Soft Tissue Puncture Biopsy Needle market opportunities vary by end market size?

How does Soft Tissue Puncture Biopsy Needle break out by Type, by Application?

This report presents a comprehensive overview of the global Soft Tissue Puncture Biopsy Needle market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Fully Automatic
  • Semi-automatic and Manual

Segment by Application

  • Public Hospital
  • Private Hospital

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Soft Tissue Puncture Biopsy Needle market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Public Hospital, Private Hospital evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Soft Tissue Puncture Biopsy Needle Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 8.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.21B
2025
Forecast
$2.1B
2032
CAGR
8.3%
2025–2032
Regiões
5
global
Key companies
BDMammotomeMedtronicMerit Medical SystemsCookBoston ScientificOlympusConMed
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Fully AutomaticSemi-automatic and Manual
By Application
Public HospitalPrivate Hospital

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Fully Automatic
  • 3.1.3 Semi-automatic and Manual
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Public Hospital
  • 4.1.3 Private Hospital
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 BD
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Mammotome
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Medtronic
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Merit Medical Systems
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Cook
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Boston Scientific
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Olympus
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 ConMed
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Micro-tech
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 KDL
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Medax
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Sterylab
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Hologic
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Weigao
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Puang Medical
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Shanghai Aisiai
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Soft Tissue Puncture Biopsy Needle market size?
The global Soft Tissue Puncture Biopsy Needle market is estimated at US$ 1.21 billion in 2025 (base year) and is projected to reach US$ 2.1 billion by 2032.
What growth rate is expected for the Soft Tissue Puncture Biopsy Needle market through 2032?
The market is expected to grow at a CAGR of 8.3% from 2026 to 2032, expanding from US$ 1.21 billion in 2025 to US$ 2.1 billion in 2032, roughly 1.7 times its base-year value.
How is Soft Tissue Puncture Biopsy Needle defined?
A needle biopsy is a procedure to obtain a sample of cells from your body for laboratory testing.
How is the Soft Tissue Puncture Biopsy Needle market segmented by type?
By type, the market is segmented into Fully Automatic and Semi-automatic and Manual.
What are the key applications of Soft Tissue Puncture Biopsy Needle?
Key applications covered include Public Hospital and Private Hospital.
Which companies are profiled in the Soft Tissue Puncture Biopsy Needle market report?
Key players profiled include BD, Mammotome, Medtronic, Merit Medical Systems, Cook, Boston Scientific, Olympus and ConMed, among 16 companies covered in total.
What geographies does the Soft Tissue Puncture Biopsy Needle market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Soft Tissue Puncture Biopsy Needle?
The soft tissue puncture biopsy needle market is driven by the increasing incidence of cancer and the growing demand for minimally invasive diagnostic procedures.
What are the main risks and barriers in the Soft Tissue Puncture Biopsy Needle market?
However, the market also faces challenges, including the need for specialized training for healthcare professionals to perform biopsy procedures safely and effectively.
Who should buy the Soft Tissue Puncture Biopsy Needle market report?
The report is intended for manufacturers and solution providers, distributors and end users in Public Hospital and Private Hospital, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Soft Tissue Puncture Biopsy Needle market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.